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 2. Abstract 
 
Background 
 
Patients   with   obsessive   compulsive   disorder   (OCD)   frequently   show   traits   of   
autism spectrum disorders (ASD).  This is one of the first studies to explore the clinical 
impact of the overlap between OCD and ASD as a categorical diagnosis. 
 
Methods 
 
A cross-sectional survey in 73 adult outpatients with DSM-IV OCD. Autistic traits were 
measured using the Autism-Spectrum Quotient (AQ).  A clinical estimate ASD diagnosis was 
made by interview using DSM-IV-TR criteria.   OCD patients with and without autistic traits 
or ASD were compared on demographic and clinical parameters and level of OCD treatment-
resistance based on treatment history.  
  
Results 
 
Thirty-four (47%) patients scored above the clinical threshold on the AQ (>=26) and 21 
(27.8%) met diagnostic criteria for ASD.  These diagnoses had not been made before.  
Patients with autistic traits showed a borderline significant increase in OCD symptom-
severity (Yale-Brown Obsessive Compulsive Scale (Y-BOCS); p=.054) and significantly 
increased   impairment of insight (Brown   Assessment   of   Beliefs   Scale; p=.01). There 
was a positive correlation between AQ and Y-BOCS scores (p =.04), but not with OCD 
treatment resistance.  
 
Conclusion 
 
There is a high prevalence of previously undiagnosed ASD in patients with OCD. ASD traits 
are associated with greater OCD symptom-severity and poor insight.  
 
 
3. Keywords  
 
Autism spectrum disorders 
Obsessive compulsive disorder 
Autistic traits 
Co-morbidity 
Autistic spectrum disorder 
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 4. Main Text 
 
Introduction 
 
Obsessive compulsive disorder (OCD) and autism spectrum disorders (ASD) are functionally 
impairing neuropsychiatric disorders associated with repetitive unwanted, urge-driven 
behaviours (compulsions) and resulting in considerable morbidity and reduced quality of life. 
In the case of OCD, the life-time prevalence is 2.3% (Baldwin et al., 2014) and 
approximately 40% of treatment-seeking cases are found to respond poorly (Fineberg et al., 
2006).  Autism spectrum disorders (ASD), in contrast, affect approximately 1% of the general 
population (Elsabbagh et al., 2012, Fombonne, 2005). ASD (classified as Pervasive 
Developmental Disorders in DSM IV-TR) is characterised by impaired social reciprocity and 
social communication, as well as repetitive and stereotyped behaviours. DSM-IV-TR 
distinguished between various subtypes of ASD. Autistic disorder is the prototypical ASD, 
diagnosed when a person shows the full array of core autistic features in conjunction with a 
delay in the development of language. By contrast, Asperger’s disorder describes those who 
have the core features of ASD, but who did not have language delay. Pervasive 
developmental disorder – not otherwise specified (PDD-NOS) is diagnosed when a person 
has marked and impairing autistic symptoms without quite meeting full criteria for autistic 
disorder or Asperger’s disorder (Mandy et al., 2011). Many of the compulsive behaviours 
observed in ASD are difficult to differentiate from those observed in OCD (Goodman et al., 
1995). 
 
Compulsions are repetitive, stereotyped acts designed to relieve distress. In the case of OCD, 
compulsions are usually generated in the context of obsessional thoughts or images and 
appear designed to neutralize the distress associated with these recurrent mental intrusions. 
For example, the compulsive urge to hand wash in association with the obsessive fear of 
contamination. Compulsions in OCD are usually experienced as unwanted, are recognised to 
be excessive or unreasonable and there is usually some attempt at resistance, although this 
can be minimal especially in chronic cases.  
 
In contrast, in ASD, although the compulsive behaviours may appear similar to those 
observed in OCD, they are not usually associated with obsessional thoughts or images. 
Instead, they appear to fulfil one or more complex functions. They may represent a learnt 
strategy for managing the distress generated by a broad range of environmental 
contingencies. They may even be experienced as rewarding or soothing.  For example, the 
need to follow an exact routine to avoid having to face unpredictability in the environment. 
They may also be used to modulate sensory arousal. For example, lower order sensory 
behaviours such as spinning. They are usually experienced as acceptable or even desirable.  
 
There is emerging empirical evidence that the repetitive behaviours of people with autism are 
usually egosyntonic, and often serve a function. For example, insistence on sameness in 
autism appears to be, in part, a deliberate strategy to manage difficult emotions such as 
anxiety and anger (Joyce et al., 2017) ; whilst autistic obsessions (i.e., focused interests) are 
usually enjoyable, drive learning and can underpin the development of a positive identity 
(Bargiela et al., 2016, Mackay and Parry, 2015). 
 
Some OCD dimensions, as identified by factor analysis (Mataix-Cols et al., 2005), occur 
commonly in ASD. They include hoarding and symmetry and arranging compulsions 
(Bejerot, 2007, Goodman et al., 1995, Russell et al., 2005). Some individuals with ASD may 
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 be able to exert control over their compulsions if or when they become aware that they are 
not socially acceptable (Bejerot, 2007). However, the differences between the compulsions of 
OCD and ASD are not always that clear-cut and there appears to be a considerable degree of 
phenotypic overlap. Therefore, in the clinical setting such as an outpatient clinic, distinctions 
between the compulsions of OCD and ASD can be difficult to make. 
 
OCD and ASD are commonly found to co-occur either in the same patient or in the same 
family. In a seminal epidemiological study, OCD was found to be common among unaffected 
(by ASD) relatives of ASD sufferers (Micali et al., 2004). Conversely, a study published by 
Bejerot and colleagues (Bejerot et al., 2001) using the Asperger’s Syndrome diagnostic 
interview (ASDI), found autistic traits to be common, affecting 13 (20%) of a sample of 64 
treatment-seeking patients with OCD. Additionally subjects with autistic traits were more 
likely to fulfil criteria for anxious and paranoid personality disorder. The authors proposed 
that OCD is often related to high functioning ASD. Another  study (Cullen et al., 2008) 
investigated the link between social communication difficulties (but not full ASD) in an OCD 
population that included family members. The study found a higher prevalence of OCD in 
those families where the proband had both OCD and social communication difficulties, 
suggesting a possible genetic link between social communication difficulties and OCD. 
Another more recent large-scale study by Meier and colleagues (Meier et al., 2015) found 
that individuals diagnosed with OCD displayed a four-fold risk of a co-morbid diagnosis of 
ASD, and that a diagnosis of ASD lent a two-fold risk of developing co-morbid OCD. The 
authors also found that a parental diagnosis of OCD significantly increased the risk of the 
development of ASD in their offspring. The authors concluded that OCD and ASD partially 
shared aetiological mechanisms, with implications for new research and clinical practice. 
 
Some studies have investigated the impact of autistic traits on the clinical presentation of 
OCD. In a study of  81 Japanese adult inpatients with OCD (Mito et al., 2014), of whom 34% 
scored above threshold on a screening instrument for autistic traits (Autism-Spectrum 
Quotient, AQ), 50% met DSM-IV-TR (Association, 2000) criteria for a diagnosis of 
pervasive developmental disorder. There were no significant differences in age, gender, 
duration of OCD at baseline or comorbidity with Axis I disorders between the OCD patients 
with and without autistic traits. However, the analysis did reveal that the group with 
significant autistic traits included a higher proportion of individuals with poor insight OCD, 
had a shorter duration of education, lower mean Global Assessment of Functioning Scale 
scores, earlier age of onset of OCD and were less likely to be married. Another significant 
finding was that a positive correlation was observed between Yale Brown Obsessive 
Compulsive scale (YBOCS) scores, representing OCD severity, and the “attention to detail”, 
“attention switching” and “imagination” subscales of the AQ. This suggests that these 
specific ASD domains may have a moderating effect on OCD severity. In contrast, Ivarrson 
and colleagues (Ivarsson and Melin, 2008), who investigated children and adolescents with 
OCD recruited from a Swedish hospital population, found that just roughly 9% showed 
symptoms of ASD. The study used a neuro psychiatric assessment supplemented by autism 
screening questionnaire covering current and preschool autistic symptoms completed by the 
parents. The study also excluded participants with a primary diagnosis of autism, however 
Asperger’s syndrome was allowed. Interestingly, this study found no correlation between 
ASD severity, OCD severity, or insight into compulsive behaviours. 
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 These preliminary findings suggest that further investigation is needed to understand the 
phenomenology and factors relevant to the aetiology, assessment, diagnosis and treatment of 
OCD with co-morbid ASD, as this overlap appears likely to impact on clinical outcomes. 
 
 
Aims 
 
The main aims of the study were to describe the distribution of ASD traits and to identify the 
proportion of OCD patients with a clinical estimate diagnosis of ASD in a treatment seeking 
UK OCD population. Secondary aims were to identify any meaningful differences in the 
demographic and clinical characteristics, of relevance to these diagnoses, associated with this 
overlap, including gender, partnership status, age of onset of OCD, age at diagnosis of OCD, 
presence of hoarding and symmetry compulsions, and degree of insight into OCD. The final 
aim of the study was to investigate whether OCD patients with autistic traits were more 
treatment-resistant in terms of previous treatments received for their OCD. 
 
 
 
Hypotheses 
 
At a UK, adulthood OCD outpatient clinic, individuals with clinically significant ASD Traits 
(including those fulfilling ASD criteria) occur at a higher frequency than in the general 
population. 
 
Patients with clinically significant ASD traits and patients with ASD diagnosis attending an 
adult OCD outpatient clinic are distinguishable from OCD patients without ASD or clinically 
significant ASD traits in terms of: 
 
a. Gender (higher proportion male)  
b. Relationship/marital status (greater proportion single/divorced) 
c. Age of onset (higher proportion early onset of OCD) 
d. Age of diagnosis of OCD (higher proportion diagnosed early) 
e. Severity of OCD symptoms (greater total Y-BOCS) 
f. Degree of insight in to symptoms of OCD (reduced) 
g. Presence of hoarding and symmetry symptoms (more common) 
 
 
Methodology 
 
The study was approved by the East of England NHS Research Ethics Committee.  
 
Participants 
 
106 consecutive treatment-seeking adult patients were approached at a specialist OCD clinic 
from March 2013 to September 2014. They all fulfilled DSM- IV-TR (Association, 2000)  
criteria for a diagnosis of OCD based on an in-depth clinical assessment by expert clinicians. 
All patients attending the clinic over this period were offered the opportunity to consent to 
the study.   
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 Instruments  
 
Patients were offered screening on the following instruments; 
 
Autism-Spectrum Quotient  
 
The Autism-Spectrum Quotient (AQ), developed by Baron Cohen and colleagues (2001), is a 
50-item self-reported screening questionnaire that measures autistic traits in adults with 
normal intelligence. The questionnaire is divided into five domains; communication, 
imagination, social skills, attention-switching and attention to detail. Each domain is 
represented by 10 categorical statements (see Table 1 for an example). According to a 
previous large study (Baron-Cohen et al., 2001), the distribution of total AQ scores in the 
general population shows a uni-modal distribution, with scores in the range 16-20/50 
occurring with the highest frequency. In contrast, high functioning adult ASD patients with 
normal IQ showed a bi-modal distribution of AQ scores with scores in the range 36-40/50 
occurring most commonly. AQ validation studies have demonstrated that, in clinical practice, 
by using a cut-off score of 26 on the total AQ, it was possible to correctly identify 83% of all 
the patients who fulfilled criteria for a DSM IV diagnosis of ASD, with a specificity of 0.52 
and sensitivity of 0.95 (Woodbury-Smith et al., 2005). 
 
[Table 1 here] 
 
Yale Brown Obsessive Compulsive Scale (Y-BOCS) and Checklist.  
 
The Y-BOCS checklist (Goodman et al., 1989b, Goodman et al., 1989a, Woody et al., 1995) 
is used to evaluate the type of OCD symptoms present or past. It is completed by the clinician 
in a semi-structured interview. It is divided into various domains relating to common 
obsessions and compulsions. The checklist leads on to the Y-BOCS itself, which is a 
validated, 10-item questionnaire rated by the clinician. Items measure the severity of OCD 
symptoms. The first 5 questions measure obsessions and the remaining 5 measure 
compulsions. Each item is rated from 0 (no symptoms) to 4 (extreme symptoms). The 
maximum total score is 40.  
 
Brown Assessment of Beliefs Scale (BABS).  
 
This clinician-rated scale measures a patient’s insight about their beliefs. It consists of seven 
dimensions; conviction, perception of others’ views of beliefs, explanation of differing views, 
fixity of ideas, attempts to disprove ideas, insight and ideas or delusions of reference. All the 
dimensions are scored on a four point Likert scale ranging from 0-4 (Eisen et al., 1998).   
  
Clinical Estimate Autism Spectrum Disorders Diagnostic Assessment. 
 
 ‘Clinical estimate’ ASD diagnosis was derived from a clinical interview, structured 
according to DSM-IV-TR criteria for autism spectrum disorders diagnoses (i.e., autism, 
Asperger’s syndrome, atypical autism), conducted by an experienced psychiatrist. These 
interviews lasted between 30 and 45 minutes each, and involved systematic questioning 
relating to each of the core, diagnostic symptoms of ASD, as set out in the DSM-IV-TR. 
Clinicians were provided with prompts and example questions, to help inform their 
investigations of each part of the ASD phenotype. For example, when investigating the 
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 presence of sensory abnormalities, recommended questions included ‘Do they have concerns 
about strong food textures?’ and ‘Have they ever cut the labels out of clothes or avoided 
certain fabrics because of sensitivity?’ Both current and past behaviour were covered, and 
decisions on whether a particular symptom was present were made on the basis of both the 
reports of the participant and observations made by the clinician during the interview.  The 
interview was recorded on an audio tape and assessed by a panel of expert clinicians. A 
clinical estimate diagnosis was reached based on a predetermined consensus principle.  
 
Intra-class correlation coefficients were calculated for agreement between the four raters on 
overall diagnosis and for each of the three types of symptoms; Diagnosis: .90 [95% CI .78, 
.95], Social reciprocity symptoms: .93 [.85, .97], Communication: .92 [.82, .96], Repetitive 
behaviour: .83 [.65, .92]. These correlations suggest a strong degree of inter-rater reliability. 
 
 
Procedure 
 
Patients were approached and tested at extended clinic appointments by a researcher.  All 
those consenting to participate provided information for a demographic questionnaire and 
completed the AQ. Participants who scored 26/50 or above were allocated to the (OCD + 
autistic traits) (OCD+AT) subgroup and were invited to participate in the autism assessment 
interview described above.  
 
Patients were additionally rated by an experienced psychiatrist for OCD severity using the Y-
BOCS, and for degree of insight using the BABS.    
 
Treatment resistance 
 
We used the patients’ treatment histories to ascertain the degree of treatment resistance.  We 
staged the patients according to prior usage of pharmacological treatment and psychological 
therapies (table 2). The staging tool was designed by the investigators to capture treatment 
response data for the purpose of the study, consistent with current evidence-based treatment 
algorithms for OCD (Stein et al., 2015). We simplified the analysis by dividing the total OCD 
group into those who had and had not been selected by their treating clinicians to join a 
highly specialised service for highly resistant OCD cases that defined entry by failure to 
respond to at least 2 courses of standard SSRI plus one course of pharmacological 
augmentation as well as two courses of cognitive behaviour therapy for OCD.  
 
[Table 2 here] 
 
Data Analysis 
 
The data were analysed with IBM SPSS Statistic 21. When comparing groups on continuous 
dependent variables, independent samples t-tests were used. Chi squared analysis was 
performed to compare groups on categorical variables. Effect sizes were presented as 
Cohen’s d (continuous variables) or odds ratios (categorical variables).  
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 Results 
 
Diagnosis  
 
73 (69%) of the eligible patients consented to take part. The mean age of the group was 44.47 
years. There was a positive significant correlation between the total Y-BOCS and the total 
AQ scores (p =.04).Thirty-four patients (47%) scored 26 or above on the AQ (OCD+AT). Of 
these, 29 were interviewed using the Clinical Estimate Autism Spectrum Disorders 
Diagnostic Assessment and 21 (62% of the OCD+AT group; 28.7% of the study sample) 
were given an estimate diagnosis of autism spectrum disorders (OCD+ASD) (see fig.1), of 
whom  12 fulfilled criteria for  Asperger’s syndrome, 7 for PDD NOS and 2 for  autism, 
based on DSM-IV criteria. 
 
[Figure 1 here] 
 
Descriptive Statistics 
 
Gender and Partnership Status 
 
 There was a slight preponderance of females (53.4%) in the total group and approximately 
two thirds of all cases were living alone, with 57.5% never having been married or lived in a 
stable partnership. A Chi squared test for independence (with Yates Continuity Correction) 
indicated that there was no significant association between the presence of autistic traits and 
gender (OCD+AT versus OCD-AT); X
2 
(1, n = 73) = .61, p = .43); or partnership status 
(OCD+AT versus OCD-AT); X
2
 (2, n=73) = 0.48, p =0.79, in the OCD sample. Similarly, 
there was no significant association between the presence of an ASD diagnosis and gender 
(OCD+ASD versus OCD-AT) X
2 
(1, n = 60) = .33, p = .57 or partnership status (OCD+AT 
versus OCD-AT); X
2
 (2, n=60) =1.36, p =.51.    
  
OCD Onset, Diagnosis, Severity and Degree of Insight and Autistic Traits  
 
[Table 3 here] 
 
The average age of onset of OCD across the whole sample was 14.58 (SD=8.53) years. In 
contrast, the mean age at diagnosis of OCD in the whole sample was 28.51 (SD=11.8) years, 
suggesting an average lag between onset and diagnosis of around 14 years. As can be seen in 
Table 3, those scoring above and below the AQ’s clinical threshold of 26 did not differ in 
their current age, reported age of onset of OCD, or in the age at which they received an OCD 
diagnosis. Table 3 shows that on the Y-BOCS ‘Compulsions’ and ‘Obsessions’ scales there 
were no differences between those above and below the AQ threshold. However, there was a 
non-significant trend (p<.054) towards those scoring with high ATs also showing increased 
overall OCD symptom severity, as measured by the Y-BOCS total score. Table 4 shows a 
comparison between AQ-defined groups for individual symptoms of OCD, as measured by 
the Y-BOCS. There was evidence that the OCD+AT group had less insight into their OCD 
symptoms than those without high ATs, as shown by the group difference on the BABS, 
which was large and significant (effect size = -.65 [-1.13, -.15], p=.01). 
 
[Table 4 here] 
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As is shown in Table 5, we also looked at those with an estimate ASD diagnosis, excluding 
those who scored above the clinical range on the AQ but were not subsequently identified as 
having ASD, and compared them to participants who had OCD, but no ASD diagnosis. No 
group differences were found in terms of current age, OCD age of onset, OCD age of 
diagnosis, insight or severity, as indexed by the Y-BOCS ‘Compulsions’, ‘Obsessions’ and 
total scores.  
 
[Table 5 here] 
  
Treatment resistance 
. 
The majority of patients across the whole sample (52/73 (71%)) had failed at least one 
evidence based treatment. However there was no significant difference between those with 
and without autistic traits in terms of treatment stage (OCD+AT versus OCD-AT; p =.31). 
Similarly, there was no significant difference between those with and without ASD and 
treatment stage (OCD+ASD vs OCD-AT; p = .43).   
 
Twenty-four (33%) patients were receiving treatment in the highly resistant OCD service. 
Owing to abnormal variance we applied the Yates Continuity Correction, which indicated 
that there was no significant association between the proportion of patients requiring 
treatment resistant OCD services and the presence of autistic traits (OCD+AT vs OCD-AT; p 
= .56) or the presence of ASD (OCD+ASD vs OCD-AT p = .29). 
 
Distribution of AQ scores 
 
[Figure 2 here] 
 
In our total OCD sample, the distribution of total AQ scores, representing the number of ASD 
traits, was found to lie mid-way between that of the general population and that of the ASD 
comparator groups (from the previously published study by Baron Cohen et al., 2001) with 
scores in the range 21-25/50 (M=24.74, SD=8.17) being endorsed most frequently (figure 2).  
The OCD sub-groups with defined autistic traits (OCD+AT) and an estimate diagnosis of 
ASD (OCD+ASD) each endorsed AQ scores between 26-30/50. Thus, the OCD patients with 
co-morbid estimate diagnosis of ASD were not seemingly scoring in general as high on the 
AQ as did a formally diagnosed ASD sample. This finding may reflect possible ascertainment 
bias in that the majority of OCD patients had not been given a clinical ASD diagnosis and 
may thus be inferred to represent a more mildly autistic group.  
 
Profile of AQ domains affected in OCD patients with autistic traits 
 
The OCD+AT group scored high in all AQ domains, most especially in the domain of 
attention switching (mean 8.45 out of 10 items endorsed) in which domain they were 
numerically more impaired than were the previously published ASD group (figure 3). The 
OCD group without autistic traits (OCD-AT) were also numerically more impaired than the 
normal population comparator group on the same domain, suggesting the presence of a 
moderating effect of OCD on this domain. Importantly, we also found that the OCD+AT 
group showed poor social skills.  
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[Figure 3 here] 
 
 
 
Discussion 
 
OCD includes a heterogeneous group of patients without a clear consensus on how to 
subdivide the disorder into clinically meaningful subtypes (Lochner and Stein, 2003). 
According to DSM–IV and DSM-5 (American Psychiatric Association. and American 
Psychiatric Association. DSM-5 Task Force., 2013)  the level of insight and the presence of 
tic represent specifiers that may determine clinical outcomes. It has been proposed that OCD 
patients with comorbid ASD may represent yet another clinically relevant 
‘neurodevelopmental’ OCD subtype, associated with a poor response to standard treatment 
(Bejerot, 2007, Russell et al., 2013, Koegel and Koegel, 1998). Alternatively, ASD 
compulsions may be mis-diagnosed as OCD, and this may explain why these patients might 
fail to respond to standard OCD treatments. In a recent brain-imaging study, Kobayashi and 
colleagues (KOBAYASHI et al., 2015) found that reductions in the volume of the left dorso-
lateral prefrontal cortex and amygdala correlated positively with AQ scores. The authors 
suggested that these changes define a biologically distinct OCD subgroup, with implications 
for the development of more appropriate therapy and treatment.  
 
In our study, we explored the co-occurrence of ASD traits and diagnosis on the clinical 
presentation and treatment outcomes of a moderately–sized sample of treatment-seeking 
OCD patients, in an attempt to better understand this inter-relationship and draw inferences 
on the role of ASD in defining a specific OCD subgroup. We found a high prevalence of ASD 
traits (47%) and diagnosis (29%) in the OCD sample. Not one of these patients had 
previously been recognized as having ASD traits, despite in many case multiple clinic visits, 
emphasising the difficulty of recognizing ASD within this clinical group and implying that 
active screening for ASD in OCD patients may be helpful.  
 
The level of ASD traits found in our study exceeded those reported by Mito and colleagues 
(2014) in a Japanese sample of adults with OCD, in which 34% and 17% showed ASD traits 
and diagnosis respectively and Bejerot and colleagues (2001), who found 20% of a child and 
adolescent cohort of OCD patients with ASD. One explanation for the higher frequency of 
autistic traits in our study may derive from the use of a lower threshold for defining this 
group. Unlike Mito et al (2010) who chose an AQ score of 32, we used a cutoff of 26, as per 
the work of Woodbury-Smith et al (2005). Judging by the distribution of the AQ scores in our 
OCD+AT group, which did not appear to differ from the distribution of AQ scores of those 
given a clinical estimate diagnosis of ASD, we believe the cut off we used was valid and that 
our findings do not over-estimate clinically relevant autistic traits in our sample. Moreover, 
we believe our frequency data may represent a conservative estimate of the frequency of 
autistic traits in the whole clinic sample, as it was our observation that a substantial 
proportion of those refusing to consent to screening for ASD (N=33) may have had autistic 
traits as well, though we were unable to validate this observation for ethical reasons. 
 
Taken together with the existing published data, our findings indicate that the prevalence of 
ASD is elevated in treatment seeking OCD patients, perhaps by at least twenty times that of 
the normal population and that we may expect roughly half of adults seeking treatment for 
OCD to demonstrate clinically relevant comorbid ASD traits.  
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The autistic traits that were the most strongly endorsed involved problems with flexibly 
shifting attention, on which ASD domain the OCD sample appeared numerically even more 
impaired than the a published ASD cohort (see figure 3). Attentional set-shifting problems are 
observed on cognitive testing in OCD (Fineberg et al., 2013) and similar abnormalities are 
also seen in ASD (Gioia et al., 2002), suggesting that an area of neurocognitive overlap 
manifesting as cognitive inflexibility exists across these two separate disorders that may 
account for these findings. However, other autistic traits not inherently associated with OCD 
were also frequently endorsed by the OCD patients in this study, including poor social, 
communication and imaginative skills, providing support for a true diagnostic overlap with 
ASD. Further studies examining the neurocognitive underpinnings of these changes may help 
to clarify the extent to which the same or different neurocognitive mechanisms (and possibly 
neural mechanisms) occur across patients with OCD, ASD and the combination of both 
disorders. The nature of these clinical changes suggests that collaboration between clinicians 
and academics with expertise in neurodevelopmental as well as psychiatric disorders may 
benefit the research and treatment of this significant patient group.  
 
In our sample, the OCD patients with autistic traits and with ASD showed a similar 
demographic profile in terms of gender distribution, employment and marital status as those 
without autistic traits. The failure to find a preponderence of males in these groups is 
consistent with other published studies (Bejerot et al., 2001, Mito et al., 2014). ASD is 
reported to be more commonly misdiagnosed in females than males and symptomatic females 
with undiagnosed ASD may as a result show over-represention in other non-ASD psychiatric 
clinics and services (Bargiela et al., 2016) . Therefore, the relative over-representation of 
females with autistic traits in our OCD service may result from ascertainment bias related to 
the general failure to recognize ASD in females and suggests that clinicians should be 
particularly careful to look for ASD in female patients presenting for treatment of OCD.  
 
In contrast to the study by Mito et al (Mito et al., 2014), the age of onset of OCD and age of 
diagnosis of OCD did not differ between the groups.  Indeed the mean age of onset of OCD 
occurred around adolescence (14-15yrs).This was contrary to expectation, as we had 
hypothesized that the presence of an early onset neuro-developmental disorder would have 
led to an earlier onset or diagnosis of OCD. Our findings suggest that the presence of autistic 
traits or of ASD may not affect the natural course of OCD. However, this data was collected 
retrospectively and patients’ recall may have been unreliable. Moreover, there was a 
considerable delay of approximately 14 years between the reported onset of illness and 
diagnosis irrespective of the presence of autistic traits or ASD, suggesting that a ceiling effect 
could have obscured a true moderating effect of ASD on age of illness onset. Our finding 
provides further sobering evidence that OCD is a poorly recognized illness (Dell’Osso et al., 
2010) with a long duration of untreated disorder. It also suggests that future research should 
explore the onset and course of OCD and ASD prospectively, in longitudinal cohorts of 
children and adolescents.  
 
OCD patients with autistic traits were more severely symptomatic on the Y-BOCS and there 
was a positive correlation between OCD and ASD scores. This finding replicates that of Mito 
et al (2014). It is commonly found that co-morbid disorders predict a greater severity of index 
illness (Fineberg et al., 2013) and this finding may therefore simply represent a non-specific 
effect reflecting the burden of having an additional mental health diagnosis. However, it was 
noteworthy that a high frequency of traits in a range of ASD domains (attention switching, 
social skills) was found in this co-morbid group. In other words, the presence co-morbid ASD 
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 brought with it an additional clinical burden related to the ASD traits themselves. The clinical 
impact of these additional problems e.g. on health related quality of life, merits further 
investigation. Based on our data, there would be grounds for investigating new treatment 
strategies, e.g. focussing on cognitive remediation, to improve cognitive flexibility and social 
skills training.  
 
The correlations between poor insight and autistic traits were also significant. Theoretically, 
poor insight should impact negatively on OCD treatment outcome (Himle et al., 2006). 
However, contrary to expectation, despite increased symptom-severity and poorer insight, the 
OCD+AT group did not appear to be more treatment refractory on the measures we used (past 
treatment history, service stream). This may also represent a ceiling effect, in as much as all 
the OCD patients had been ill for a very long time and there was a high proportion of 
treatment-resistant cases among them. In addition, the retrospective nature of the methods 
used to infer treatment resistance was open to error. 
 
Considering the study findings of high prevalence rates of AT/ASD, the non-significant trend 
toward a positive correlation between AQ and Y-BOCS scores, and the negative results of 
most comparisons between the study groups, the possibility of phenomenological overlap 
between some autistic traits (as measured by the AQ) and OCD symptoms or clinical features 
needs to be acknowledged. It is possible that the AQ may have been measuring behaviours 
that are also frequent among OCD sufferers without autistic traits. Therefore, instead of 
under-identification, the possibility of over-identification of ASD or ASD traits (i.e. false-
positive cases) such that OCD compulsions/avoidant behaviours may have been mis-
interpreted as autistic traits, should be considered. However, the finding of significantly 
poorer insight in the OCD + AT group provides some evidence that a high AQ score may 
indeed reflect a separate process illness. Furthermore, the finding that 21 out of 34 patients 
scoring above 25 on the AQ were, following a detailed clinical assessment, judged to fulfil 
DSM-IV ASD criteria, provides stronger evidence supporting ASD comorbidity in a majority 
of these patients. 
 
Limitations 
 
We must acknowledge the possibility of false-positives due to the low specificity of the AQ 
and the issue of clinical overlap of observed behaviours. In addition, although the BABS is 
the established scale for measuring insight in OCD, the score may be influenced by OCD 
symptoms content and cannot be totally relied upon (Brakoulias and Starcevic, 2011) . The 
non-significant trend in total Y-BOCS score in the OCD + AT group may have resulted from 
a type 2 error. Other psychiatric comorbidities were not investigated and could also have had 
an impact on several explanatory variables (e.g. partnership status, level of insight), as well as 
on treatment outcome. The fact that the participants were treated at a specialized OCD clinic 
may limit the external validity of the study. 
 
Conclusions 
 
The high prevalence of previously undiagnosed ASD in both male and female outpatients 
with treatment seeking OCD, and the associated impairment on scales measuring insight, 
cognitive flexibility and social communication skills, indicates a clinically relevant 
neurodevelopmental OCD subgroup that merits further multidisciplinary investigation to 
improve recognition and develop new and more effective clinical treatments and services to 
optimize outcomes.  
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 5. Key Points 
 
• ASD traits were found to commonly occur in OCD outpatients  
• In the main, the presence of comorbid ASD traits had been previously overlooked 
by clinicians.  
• OCD patients with high levels of ASD traits showed greater impairment of 
insight, social skills, social communication and cognitive flexibility. 
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9. Legends of Tables and figures 
 
 
 
Figure 1 legend 
 
 
 
 
 
 
 
 
 
Figure 2 legend 
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 10. Tables 
 
Table 1. An example of a statement for each of the AQ domains 
 
Domain 
 
 
Statement 
 
Social skills 
 
 
I find it hard to make friends. 
 
Attention switching 
 
I frequently get so absorbed in one activity that I lose sight of 
others. 
 
 
Attention to detail 
 
 
I am fascinated by numbers. 
 
Communication 
 
Other people tell me what I have said is impolite even though I 
think it is polite. 
 
Imagination 
 
 
When I am reading a story book, I find it difficult to figure out the 
characters’ intentions. 
 
Table 2: Treatment stage  
 
Stage 
 
Details  
 
 
Stage 1 
 
 
Treatment naive  
 
Stage 2 
 
 
Inadequate course of evidence based treatment 
 
Stage 3 
 
Responded to course of treatment  
 
 
Stage 4 
 
Failed one course of CBT or evidence based pharmacological 
treatment with good adherence 
 
Stage 5 
 
Failed 2 courses of CBT or 2 courses evidence based pharmacological 
treatment with good adherence 
 
 
Stage 6 
 
Failed 2 courses of CBT including home based therapy or evidence 
based pharmacological therapy augmented with antipsychotic or high 
dose SSRI 
 
Stage 7 
 
Failed 2 courses of CBT including inpatient CBT or augmentation of 
evidenced based pharmacological therapy with novel compounds 
 
Ac
ce
pte
d M
an
us
cri
pt
D
ow
nl
oa
de
d 
by
 [U
CL
 L
ibr
ary
 Se
rv
ice
s] 
at 
08
:19
 01
 A
ug
us
t 2
01
7 
 Table 3. Comparison of OCD characteristics of those scoring above and below Autism 
Spectrum Quotient threshold  
 AQ ≥ 26 AQ < 26 Effect size 
 
P 
 n=34 n=39   
 Mean (SD) Mean (SD) Cohen’s d 
[95% CIs] 
 
Age at time of current study in 
years 
45.18 
(12.16) 
43.85 
(12.25) 
-.11 
[-.57, .35] 
.644 
Age at OCD onset in years 15.11 
(9.17) 
14.10 
(1.29) 
-.11 
[-.58, .34] 
.993 
Age at OCD diagnosis in years 29.21 
(13.80) 
29.18 
(10.10) 
.00 
[-.46, .46] 
.606 
Age started OCD treatment in 
years 
30.29 
(13.85) 
29.90 
(10.68) 
-.03 
[-.49, .43] 
.891 
YBOCS OCD symptoms     
Compulsions 11.60 
(3.97) 
9.84 
(4.52) 
-.41 
[-.90, .08] 
.104 
Obsessions 10.28 
(4.41) 
9.21 
(4.07) 
-.25 
[-.74, .24] 
.310 
Total 21.82 
(7.43) 
18.05 
(7.93) 
-.49 
[-.98, .01] 
.054 
BABS Total 8.10 
(5.78) 
4.84 
(4.42) 
-.65 
[-1.13, -.15] 
.011 
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 Table 4 Y-BOCS symptom checklist items for those scoring above and below threshold on 
the Autism Quotient 
 
 AQ ≥ 26 AQ < 26 Odds ratio 
[95% CI] 
P 
 n=30 n=39   
 n with 
symptom (%) 
n (%)   
Obsessions     
Aggressive
1
  19 (65.5%) 22 (56.4%) 1.47  
[.49, 4.49] 
.448 
Contamination
1
 18 (62.1%) 27 (69.2%) 
 
.72 
[.23, 2.26] 
.537 
Sexual
1
 7 (24.1%) 6 (15.4%) 1.75 
[.43, 7.18] 
.364 
Hoarding
1
 12 (41.4%) 14 (35.9) 1.26 
[.42, 3.78] 
.645 
Religious 
1
 7 (24.2%) 8 (20.5%) 1.23 
[.33, 4.54] 
.721 
Symmetry
2
 11 (36.7%) 15 (38.5%) .93 
[.31, 2.76] 
.878 
Miscellaneous
2
 18 (60.0%) 22 (57.9%) 1.09 
[.37, 3.24] 
.860 
Compulsions     
Somatic 8 (26.7%) 18 (46.15) .42 
[.13, 1.31] 
.098 
Cleanliness 19 (63.3%) 26 (66.7%) .86 
[.28, 2.64] 
.773 
Checking 21 (70.0%) 28 (71.8%) .92 
[.28, 3.01] 
.871 
Repeating 19 (63.3%) 22 (56.4%) 1.33 
[.45, 3.99] 
.562 
Counting 16 (53.3%) 17 (43.6%) 1.48 
[.51, 4.29] 
.422 
Ordering 11 (36.7%) 14 (35.9%) 1.03 
[.34, 3.11] 
.948 
Hoarding 8 (26.7%) 13 (33.3%) .72 
[.22, 2.33] 
.551 
Miscellaneous 23 (76.7%) 23 (59.0%) 2.29 
[.71, 7.79] 
.122 
1AQ≥26 n=29  
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 Table 5. Comparison of OCD characteristics of those with and without estimate ASD 
diagnosis 
 ASD Non ASD Effect size 
 
P 
 n=21 n=48   
 Mean (SD) Mean (SD) Cohen’s d 
[95% CIs] 
 
Age at time of current study 
in years 
45.33 
(11.41) 
44.41 
(12.64) 
-.07 
[-.59, .44] 
.776 
Age at OCD onset in years 12.38  
(5.70) 
14.94 
(9.02) 
.31 
[-.20, .83] 
.236 
Age at OCD diagnosis in 
years 
30.57 
(13.58) 
28.68 
(11.45) 
-.16 
[-.67, .36] 
.555 
Age started OCD treatment 
in years 
    
YBOCS OCD symptoms     
Compulsions 10.67 
(3.44) 
10.33 
(4.61) 
-.08 
[-.62, .47] 
.778 
Obsessions 9.22  
(4.19) 
9.61 
(4.17) 
.09 
[-.45, .64] 
.310 
Total 19.89 
(6.53) 
19.07 
(8.16) 
-.11 
[-.65, .44] 
.704 
BABS Total 7.68  
(6.05) 
5.70 
(4.99) 
-.37 
[-.91, .17] 
.175 
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 11. Figures 
 
 
Figure 1. Number of participants recruited into each group 
Consecutive OCD  
clinic attendees 
N=106 
  
 
Refused 
N=33 
>26 on 
AQ 
 
<26 on 
AQ 
 
 
Consented 
N=73 
OCD-AT 
N=39 
OCD+AT 
N=34 
OCD+ASD 
N=21 
OCD+AT-ASD 
N=8 
Refused 
N=5 
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 Figure 2 Distribution of total AQ  scores in the OCD sample (…….), compared to published 
AQ data from the general population (unbroken line) and high functioning ASD control 
groups (-------) derived from a published study (Baron-Cohen et al., 2001) 
 
 
Figure 3. Profile of AQ domains affected in OCD patients with autistic traits 
0
2
4
6
8
10
12
M
e
an
 S
co
re
 
AQ Domains 
OCD + AT N = 34
 OCD - AT N =  39
Controls  N = 174
ASD N = 58
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
0 - 05 06 -
10
11 -
15
16 -
20
21 -
25
26 -
30
31 -
35
36 -
40
41 -
45
46 -
50
p
e
rc
e
n
t 
o
f 
p
at
ie
n
ts
 
AQ scores 
OCD N = 73
general population N = 174
ASD N = 58
Ac
ce
pte
d M
an
us
cri
pt
D
ow
nl
oa
de
d 
by
 [U
CL
 L
ibr
ary
 Se
rv
ice
s] 
at 
08
:19
 01
 A
ug
us
t 2
01
7 
